Similar results of the CUDC-907-mediated blockage of the S and G2/M phases were shown for pancreatic and thyroid cancers via the downregulation of the cell cycle regulators cyclin B1, AURKA, and PLK1 [33,35]. This evidence concerns the gene AURKA and thyroid gland carcinoma.